SlideShare una empresa de Scribd logo
1 de 22
Module 5 | Slide 1 of 22 January 2006
Sections 5 and 6
Basic Principles of GMP
Complaints and Recalls
Module 5 | Slide 2 of 22 January 2006
Complaints and Recalls
Objectives
To identify the key issues in product complaint and recall
handling
To understand the specific requirements for organization,
procedures and resources
To understand and develop actions to resolve current issues
applicable to you
Module 5 | Slide 3 of 22 January 2006
5.1
Complaints and Recalls
Complaints: Principle
“All complaints and other information concerning potentially
defective products must be carefully reviewed according to
written procedures and corrective action should be taken.”
Module 5 | Slide 4 of 22 January 2006
5.2 – 5.3
Complaints and Recalls
Complaints Procedure - I
Designated responsible person:
To handle complaint
Decide on measure to be taken
May be authorized person - if not, must advise authorized
person of results
Sufficient support staff
Access to records
Written procedure (SOP):
Describes action to be taken
Includes need to consider a recall (e.g. possible product
defect)
Module 5 | Slide 5 of 22 January 2006
5.4 – 5.6
Complaints and Recalls
Complaints Procedure - II
 Thorough investigation:
QC involved
With special attention to establish whether "counterfeiting" may
have been the cause
Fully recorded investigation – reflect all the details
 Due to product defect (discovered or suspected):
Consider checking other batches
Batches containing reprocessed product
Module 5 | Slide 6 of 22 January 2006
5.7 – 5.9
Complaints and Recalls
Complaints Procedure - III
 Investigation and evaluation should result in appropriate follow-up
actions
May include a "recall"
 All decisions and measures taken should be recorded
 Referenced in batch records
 Records reviewed - trends and recurring problems
Module 5 | Slide 7 of 22 January 2006
5.10
Complaints and Recalls
Other actions
Inform competent authorities in case of serious quality
problems such as:
Faulty manufacture
Product deterioration
Counterfeiting
Module 5 | Slide 8 of 22 January 2006
Complaints and Recalls
Classification of Defects
 If complaint is justified, then there has been a failure of the quality
system
 Once defect has been identified, company should be dealing with it
in an appropriate way, even recall
 The definition of defects is useful
 The following system has been found in some countries (but it is
not a WHO guideline):
Critical defects
Major defects
Other defects
Module 5 | Slide 9 of 22 January 2006
Complaints and Recalls
Critical Defects
Those defects which can be life-threatening and require the
company to take immediate action by all reasonable means,
whether in or out of business hours
Examples
Product labelled with incorrect name or incorrect strength
Counterfeit or deliberately tampered-with product
Microbiological contamination of a sterile product
Module 5 | Slide 10 of 22 January 2006
Complaints and Recalls
Major Defects
 Those defects which may put the patient at some risk but are not
life-threatening and will require the batch recall or product
withdrawal within a few days
Examples
Any labelling/leaflet misinformation (or lack of information)
which represents a significant hazard to the patient
Microbial contamination of non-sterile products with some risk
for patients
Non-compliance to specifications (e.g. active ingredient
assay)
Module 5 | Slide 11 of 22 January 2006
Complaints and Recalls
Other Defects
Those defects which present only a minor risk to the patient —
batch recall or product withdrawal would normally be initiated
within a few days
Examples
Readily visible isolated packaging/closure faults
Contamination which may cause spoilage or dirt and where
there is minimal risk to the patient
Module 5 | Slide 12 of 22 January 2006
Complaints and Recalls
Reasons for Recall
Customer complaint
Detection of GMP failure after release
Result from the ongoing stability testing
Request by the national authorities
Result of an inspection
Known counterfeiting or tampering
Adverse reaction reporting
Module 5 | Slide 13 of 22 January 2006
Basic Principles of GMP
Sample slide from slide no 13
 The photo shows an
active tablet in the row
of placebos in a bi-phasic
oral contraceptive
blister pack
Detection of GMP failure
Module 5 | Slide 14 of 22 January 2006
6.1
Complaints and Recalls
Product Recalls: Principle
“There should be a system to recall from the market promptly and
effectively, products known or suspected to be defective.”
Module 5 | Slide 15 of 22 January 2006
Complaints and Recalls
Definition
Recall
Removal from the market of specified batches of a product
May refer to one batch or all batches of product
Module 5 | Slide 16 of 22 January 2006
6.2
Complaints and Recalls
Recall Procedure - I
Designated responsible person (should be the "authorized
person")
To execute and coordinate recalls
Decide on measure to be taken
Sufficient support staff
To handle all aspects and urgency of recall
Module 5 | Slide 17 of 22 January 2006
6.3 – 6.4
Complaints and Recalls
SOP for Recall
Established, written and authorized
Detailed actions to be taken
Regularly reviewed and updated
Capable of rapid operation to required level of distribution
chain, e.g. hospital and pharmacy level
Store recalled products in a secure, segregated area
Module 5 | Slide 18 of 22 January 2006
6.6
Complaints and Recalls
Distribution Records
Distribution records available to authorized person and contain
sufficient information on:
Wholesalers
Direct customers
Export locations
Batch numbers and quantities
Including for clinical tests and medical samples
to permit effective recall
Module 5 | Slide 19 of 22 January 2006
6.5, 6.7, 6.8
Complaints and Recalls
Progress of recall
Monitor and record the progress during the recall
Inform all competent authorities of all countries where the given
product had been distributed
Final report should include reconciliation between delivered and
recovered products
Record of the disposition of the product
Effectiveness of procedure tested and evaluated from time to
time!
Module 5 | Slide 20 of 22 January 2006
Complaints and Recalls
Group Session
Collect 3 examples of complaints or recalls from your
experience
Describe the actions to be taken by the company or authority
and the implications for all interested parties
Suggest a classification of the complaint or recall into critical
(life-threatening), major or other
Module 5 | Slide 21 of 22 January 2006
Complaints and Recalls
Possible Issues – I
No response to justified complaints
Response to unjustified complaints
Failure to recall
Failure to correct frequent complaints
No resources to investigate
No senior management support
Senior management interference
Module 5 | Slide 22 of 22 January 2006
Complaints and Recalls
Possible Issues – II
No distribution information/batch records
No access to records
Inability to contact government during holidays/weekends
Disagreement on severity of defect

Más contenido relacionado

La actualidad más candente

Market complaints and product recall
Market complaints and product recallMarket complaints and product recall
Market complaints and product recallpaideeksha
 
Annual product reviews
Annual product reviewsAnnual product reviews
Annual product reviewsSyed Shakeeb
 
Complaints and recall handling
Complaints and recall handlingComplaints and recall handling
Complaints and recall handlinghusna05
 
Latest trends in manufacturing quality
Latest trends in manufacturing qualityLatest trends in manufacturing quality
Latest trends in manufacturing qualityTGA Australia
 
Complaint handling in pharmaceutical companies,product recall,retention recor...
Complaint handling in pharmaceutical companies,product recall,retention recor...Complaint handling in pharmaceutical companies,product recall,retention recor...
Complaint handling in pharmaceutical companies,product recall,retention recor...swrk
 
Complaints in Quality Management System
Complaints in Quality Management SystemComplaints in Quality Management System
Complaints in Quality Management SystemMayuriMore15
 
1 3 gmp-purpose-principles-guidelines
1 3 gmp-purpose-principles-guidelines1 3 gmp-purpose-principles-guidelines
1 3 gmp-purpose-principles-guidelinesChi Thao
 
Complaints and recalls
Complaints and recallsComplaints and recalls
Complaints and recallsKandarp KT
 
Quality & GMP Presentation
Quality & GMP PresentationQuality & GMP Presentation
Quality & GMP Presentationmayydabajwa
 
Good manufacturing practices for complementary medicines
Good manufacturing practices for complementary medicinesGood manufacturing practices for complementary medicines
Good manufacturing practices for complementary medicinesTGA Australia
 
Quality audit slideshare
Quality audit slideshare Quality audit slideshare
Quality audit slideshare chaitrali1995
 

La actualidad más candente (20)

Market complaints and product recall
Market complaints and product recallMarket complaints and product recall
Market complaints and product recall
 
Annual product reviews
Annual product reviewsAnnual product reviews
Annual product reviews
 
Quality management - WHO GMP training
Quality management - WHO GMP trainingQuality management - WHO GMP training
Quality management - WHO GMP training
 
Complaints and recall handling
Complaints and recall handlingComplaints and recall handling
Complaints and recall handling
 
Tài liệu (phần 1) | Tài liệu GMP
Tài liệu (phần 1) | Tài liệu GMPTài liệu (phần 1) | Tài liệu GMP
Tài liệu (phần 1) | Tài liệu GMP
 
Part 1 Documentation - WHO GMP training
Part 1 Documentation - WHO GMP training Part 1 Documentation - WHO GMP training
Part 1 Documentation - WHO GMP training
 
GMP Inspection Process: Types of GMP inspection
GMP Inspection Process: Types of GMP inspectionGMP Inspection Process: Types of GMP inspection
GMP Inspection Process: Types of GMP inspection
 
Tài liệu (phần 2) | Tài liệu GMP
Tài liệu (phần 2) | Tài liệu GMPTài liệu (phần 2) | Tài liệu GMP
Tài liệu (phần 2) | Tài liệu GMP
 
Latest trends in manufacturing quality
Latest trends in manufacturing qualityLatest trends in manufacturing quality
Latest trends in manufacturing quality
 
Complaint handling in pharmaceutical companies,product recall,retention recor...
Complaint handling in pharmaceutical companies,product recall,retention recor...Complaint handling in pharmaceutical companies,product recall,retention recor...
Complaint handling in pharmaceutical companies,product recall,retention recor...
 
Thiết bị | Tài liệu GMP
Thiết bị | Tài liệu GMPThiết bị | Tài liệu GMP
Thiết bị | Tài liệu GMP
 
Complaints in Quality Management System
Complaints in Quality Management SystemComplaints in Quality Management System
Complaints in Quality Management System
 
1 3 gmp-purpose-principles-guidelines
1 3 gmp-purpose-principles-guidelines1 3 gmp-purpose-principles-guidelines
1 3 gmp-purpose-principles-guidelines
 
Complaints and recalls
Complaints and recallsComplaints and recalls
Complaints and recalls
 
Quality & GMP Presentation
Quality & GMP PresentationQuality & GMP Presentation
Quality & GMP Presentation
 
Mfr
MfrMfr
Mfr
 
National gmp 2072
National gmp 2072National gmp 2072
National gmp 2072
 
Good manufacturing practices for complementary medicines
Good manufacturing practices for complementary medicinesGood manufacturing practices for complementary medicines
Good manufacturing practices for complementary medicines
 
Quality Review
Quality ReviewQuality Review
Quality Review
 
Quality audit slideshare
Quality audit slideshare Quality audit slideshare
Quality audit slideshare
 

Destacado

Lululemon Handout
Lululemon HandoutLululemon Handout
Lululemon HandoutJake Gordon
 
How to Survive and Thrive During a Food Recall Media Crisis
How to Survive and Thrive During a Food Recall Media CrisisHow to Survive and Thrive During a Food Recall Media Crisis
How to Survive and Thrive During a Food Recall Media CrisisKatz Marketing Solutions
 
The State of the Recall, By the Numbers
The State of the Recall, By the NumbersThe State of the Recall, By the Numbers
The State of the Recall, By the NumbersConsumerBell
 
Product recalls 24.04.13
Product recalls 24.04.13Product recalls 24.04.13
Product recalls 24.04.13Ravikeerthi Rao
 
SOP For Product Recall
SOP For Product RecallSOP For Product Recall
SOP For Product Recallmuna_ali
 
Complaint and recall handling
Complaint and recall handlingComplaint and recall handling
Complaint and recall handlingDolly Gabriola
 
Complaint management system
Complaint management systemComplaint management system
Complaint management systemMitesh Patel
 
Customer complaints management system
Customer complaints management systemCustomer complaints management system
Customer complaints management systemjeanet10
 
Handling Customer Complaints
Handling  Customer ComplaintsHandling  Customer Complaints
Handling Customer ComplaintsKaruna Parmar
 
InstantGMP Compliance Series - Complaints and Recalls
InstantGMP Compliance Series - Complaints and RecallsInstantGMP Compliance Series - Complaints and Recalls
InstantGMP Compliance Series - Complaints and RecallsInstantGMP™
 
Customer Complaint Management
Customer Complaint ManagementCustomer Complaint Management
Customer Complaint ManagementFaakor Agyekum
 

Destacado (14)

Lululemon Handout
Lululemon HandoutLululemon Handout
Lululemon Handout
 
How to Survive and Thrive During a Food Recall Media Crisis
How to Survive and Thrive During a Food Recall Media CrisisHow to Survive and Thrive During a Food Recall Media Crisis
How to Survive and Thrive During a Food Recall Media Crisis
 
The State of the Recall, By the Numbers
The State of the Recall, By the NumbersThe State of the Recall, By the Numbers
The State of the Recall, By the Numbers
 
Complaints , quality defects & recalls - New EMA Requirements
 Complaints , quality defects & recalls - New EMA Requirements Complaints , quality defects & recalls - New EMA Requirements
Complaints , quality defects & recalls - New EMA Requirements
 
Product recalls 24.04.13
Product recalls 24.04.13Product recalls 24.04.13
Product recalls 24.04.13
 
Complaints & Recalls
Complaints & RecallsComplaints & Recalls
Complaints & Recalls
 
SOP For Product Recall
SOP For Product RecallSOP For Product Recall
SOP For Product Recall
 
Complaint and recall handling
Complaint and recall handlingComplaint and recall handling
Complaint and recall handling
 
Product recall overview
Product recall overviewProduct recall overview
Product recall overview
 
Complaint management system
Complaint management systemComplaint management system
Complaint management system
 
Customer complaints management system
Customer complaints management systemCustomer complaints management system
Customer complaints management system
 
Handling Customer Complaints
Handling  Customer ComplaintsHandling  Customer Complaints
Handling Customer Complaints
 
InstantGMP Compliance Series - Complaints and Recalls
InstantGMP Compliance Series - Complaints and RecallsInstantGMP Compliance Series - Complaints and Recalls
InstantGMP Compliance Series - Complaints and Recalls
 
Customer Complaint Management
Customer Complaint ManagementCustomer Complaint Management
Customer Complaint Management
 

Similar a Khiếu nại và thu hồi | Tài liệu GMP

Presentation Recall of Therapeutic Goods – Overview
Presentation Recall of Therapeutic Goods – Overview Presentation Recall of Therapeutic Goods – Overview
Presentation Recall of Therapeutic Goods – Overview TGA Australia
 
Guidelines on food recall
Guidelines on food recallGuidelines on food recall
Guidelines on food recallPRATIBHA SINGH
 
Guidelines on food recall
Guidelines on food recallGuidelines on food recall
Guidelines on food recallpratibha1984
 
Unit 4 Complaints.pptx
Unit 4 Complaints.pptxUnit 4 Complaints.pptx
Unit 4 Complaints.pptxAshwiniBhoir2
 
Market complaints & product recall
Market complaints & product recallMarket complaints & product recall
Market complaints & product recallkirankumarsolanki3
 
Awareness training on HACCP & ISO 22000
Awareness training on HACCP & ISO 22000Awareness training on HACCP & ISO 22000
Awareness training on HACCP & ISO 22000Farid Ud Din
 
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016TGA Australia
 
QMS for Medical Devices.pptx
QMS for Medical Devices.pptxQMS for Medical Devices.pptx
QMS for Medical Devices.pptxPlavAnan
 
Haccp gamp .final 2015 rakesh
Haccp gamp .final 2015 rakeshHaccp gamp .final 2015 rakesh
Haccp gamp .final 2015 rakeshRakesh Wani
 
GMP compliances of Audit
GMP compliances of AuditGMP compliances of Audit
GMP compliances of AuditMegha bhise
 
Medical Devices Product Lifecycle
Medical Devices Product LifecycleMedical Devices Product Lifecycle
Medical Devices Product LifecycleSanthiNori1
 
Post marketing surveillance
Post marketing surveillancePost marketing surveillance
Post marketing surveillanceDhruvi50
 
Complaints and recalls himanshu
Complaints and recalls himanshuComplaints and recalls himanshu
Complaints and recalls himanshuhimanshu kamboj
 
COMPLAINTS. UNIT IV
COMPLAINTS. UNIT IVCOMPLAINTS. UNIT IV
COMPLAINTS. UNIT IVSUJITHA MARY
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory AffairsNamdeo Shinde
 

Similar a Khiếu nại và thu hồi | Tài liệu GMP (20)

Complaints and recalls - WHO GMP training
Complaints and recalls - WHO GMP trainingComplaints and recalls - WHO GMP training
Complaints and recalls - WHO GMP training
 
Presentation Recall of Therapeutic Goods – Overview
Presentation Recall of Therapeutic Goods – Overview Presentation Recall of Therapeutic Goods – Overview
Presentation Recall of Therapeutic Goods – Overview
 
Guidelines on food recall
Guidelines on food recallGuidelines on food recall
Guidelines on food recall
 
Guidelines on food recall
Guidelines on food recallGuidelines on food recall
Guidelines on food recall
 
Unit 4 Complaints.pptx
Unit 4 Complaints.pptxUnit 4 Complaints.pptx
Unit 4 Complaints.pptx
 
Market complaints & product recall
Market complaints & product recallMarket complaints & product recall
Market complaints & product recall
 
RECALL.pptx
RECALL.pptxRECALL.pptx
RECALL.pptx
 
Awareness training on HACCP & ISO 22000
Awareness training on HACCP & ISO 22000Awareness training on HACCP & ISO 22000
Awareness training on HACCP & ISO 22000
 
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
 
QMS for Medical Devices.pptx
QMS for Medical Devices.pptxQMS for Medical Devices.pptx
QMS for Medical Devices.pptx
 
Closing the Gap
Closing the GapClosing the Gap
Closing the Gap
 
Haccp gamp .final 2015 rakesh
Haccp gamp .final 2015 rakeshHaccp gamp .final 2015 rakesh
Haccp gamp .final 2015 rakesh
 
GMP
GMPGMP
GMP
 
GMP by WHO
GMP by WHOGMP by WHO
GMP by WHO
 
GMP compliances of Audit
GMP compliances of AuditGMP compliances of Audit
GMP compliances of Audit
 
Medical Devices Product Lifecycle
Medical Devices Product LifecycleMedical Devices Product Lifecycle
Medical Devices Product Lifecycle
 
Post marketing surveillance
Post marketing surveillancePost marketing surveillance
Post marketing surveillance
 
Complaints and recalls himanshu
Complaints and recalls himanshuComplaints and recalls himanshu
Complaints and recalls himanshu
 
COMPLAINTS. UNIT IV
COMPLAINTS. UNIT IVCOMPLAINTS. UNIT IV
COMPLAINTS. UNIT IV
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory Affairs
 

Más de Công ty cổ phần GMPc Việt Nam | Tư vấn GMP, HS GMP, CGMP ASEAN, EU GMP, WHO GMP

Más de Công ty cổ phần GMPc Việt Nam | Tư vấn GMP, HS GMP, CGMP ASEAN, EU GMP, WHO GMP (20)

Danh sách các dược liệu đã được đánh giá đạt cấp Giấy chứng nhận GACP
Danh sách các dược liệu đã được đánh giá đạt cấp Giấy chứng nhận GACPDanh sách các dược liệu đã được đánh giá đạt cấp Giấy chứng nhận GACP
Danh sách các dược liệu đã được đánh giá đạt cấp Giấy chứng nhận GACP
 
2024 List of gmp project (Updated T1) .pdf
2024 List of gmp project  (Updated T1) .pdf2024 List of gmp project  (Updated T1) .pdf
2024 List of gmp project (Updated T1) .pdf
 
Danh mục dự án đã được tư vấn bởi GMPC 2011-2023 Cập nhật T1.2024.pdf
Danh mục dự án đã được tư vấn bởi GMPC 2011-2023 Cập nhật T1.2024.pdfDanh mục dự án đã được tư vấn bởi GMPC 2011-2023 Cập nhật T1.2024.pdf
Danh mục dự án đã được tư vấn bởi GMPC 2011-2023 Cập nhật T1.2024.pdf
 
PROFILE GMPC VIETNAM TIENG ANH - 2024.pdf
PROFILE GMPC VIETNAM TIENG ANH - 2024.pdfPROFILE GMPC VIETNAM TIENG ANH - 2024.pdf
PROFILE GMPC VIETNAM TIENG ANH - 2024.pdf
 
Profile GMPC Viet Nam - Tieng Viet - 2024.pdf
Profile GMPC Viet Nam - Tieng Viet - 2024.pdfProfile GMPC Viet Nam - Tieng Viet - 2024.pdf
Profile GMPC Viet Nam - Tieng Viet - 2024.pdf
 
Hồ sơ năng lực chi tiết GMPc Việt Nam 2024.pdf
Hồ sơ năng lực chi tiết GMPc Việt Nam 2024.pdfHồ sơ năng lực chi tiết GMPc Việt Nam 2024.pdf
Hồ sơ năng lực chi tiết GMPc Việt Nam 2024.pdf
 
Danh mục dự án đã được tư vấn bởi GMPC 2011-2023 Cập nhật T1.2024.pdf
Danh mục dự án đã được tư vấn bởi GMPC 2011-2023 Cập nhật T1.2024.pdfDanh mục dự án đã được tư vấn bởi GMPC 2011-2023 Cập nhật T1.2024.pdf
Danh mục dự án đã được tư vấn bởi GMPC 2011-2023 Cập nhật T1.2024.pdf
 
Danh sách các dược liệu đã được đánh giá đạt cấp Giấy chứng nhận GACP (5.9.20...
Danh sách các dược liệu đã được đánh giá đạt cấp Giấy chứng nhận GACP (5.9.20...Danh sách các dược liệu đã được đánh giá đạt cấp Giấy chứng nhận GACP (5.9.20...
Danh sách các dược liệu đã được đánh giá đạt cấp Giấy chứng nhận GACP (5.9.20...
 
Đánh giá việc đáp ứng Thực hành tốt nuôi trồng, thu hái dược liệu và các nguy...
Đánh giá việc đáp ứng Thực hành tốt nuôi trồng, thu hái dược liệu và các nguy...Đánh giá việc đáp ứng Thực hành tốt nuôi trồng, thu hái dược liệu và các nguy...
Đánh giá việc đáp ứng Thực hành tốt nuôi trồng, thu hái dược liệu và các nguy...
 
Đánh giá thay đổi, bổ sung việc đáp ứng Thực hành tốt nuôi trồng, thu hái dượ...
Đánh giá thay đổi, bổ sung việc đáp ứng Thực hành tốt nuôi trồng, thu hái dượ...Đánh giá thay đổi, bổ sung việc đáp ứng Thực hành tốt nuôi trồng, thu hái dượ...
Đánh giá thay đổi, bổ sung việc đáp ứng Thực hành tốt nuôi trồng, thu hái dượ...
 
Đánh giá định kì việc duy trì đáp ứng Thực hành tốt nuôi trồng, thu hái dược ...
Đánh giá định kì việc duy trì đáp ứng Thực hành tốt nuôi trồng, thu hái dược ...Đánh giá định kì việc duy trì đáp ứng Thực hành tốt nuôi trồng, thu hái dược ...
Đánh giá định kì việc duy trì đáp ứng Thực hành tốt nuôi trồng, thu hái dược ...
 
Cấp lại Giấy chứng nhận dược liệu đạt GACP trong trường hợp bị mất hoặc hư hỏ...
Cấp lại Giấy chứng nhận dược liệu đạt GACP trong trường hợp bị mất hoặc hư hỏ...Cấp lại Giấy chứng nhận dược liệu đạt GACP trong trường hợp bị mất hoặc hư hỏ...
Cấp lại Giấy chứng nhận dược liệu đạt GACP trong trường hợp bị mất hoặc hư hỏ...
 
Thông tư số 38.2021 TT-BYT.pdf
Thông tư số 38.2021 TT-BYT.pdfThông tư số 38.2021 TT-BYT.pdf
Thông tư số 38.2021 TT-BYT.pdf
 
Thông tư số 19.2018 TT-BYT.pdf
Thông tư số 19.2018 TT-BYT.pdfThông tư số 19.2018 TT-BYT.pdf
Thông tư số 19.2018 TT-BYT.pdf
 
Thông tư số 21.2018 TT-BYT.pdf
Thông tư số 21.2018 TT-BYT.pdfThông tư số 21.2018 TT-BYT.pdf
Thông tư số 21.2018 TT-BYT.pdf
 
Thông tư số 05.2019 TT-BYT.pdf
Thông tư số 05.2019 TT-BYT.pdfThông tư số 05.2019 TT-BYT.pdf
Thông tư số 05.2019 TT-BYT.pdf
 
Thông tư 48.2018 TT-BYT.pdf
Thông tư 48.2018 TT-BYT.pdfThông tư 48.2018 TT-BYT.pdf
Thông tư 48.2018 TT-BYT.pdf
 
Danh mục các dược liệu công bố tiêu chuẩn chất lượng.pdf
Danh mục các dược liệu công bố tiêu chuẩn chất lượng.pdfDanh mục các dược liệu công bố tiêu chuẩn chất lượng.pdf
Danh mục các dược liệu công bố tiêu chuẩn chất lượng.pdf
 
Công văn số 1895 YDCT-QLD.pdf
Công văn số 1895 YDCT-QLD.pdfCông văn số 1895 YDCT-QLD.pdf
Công văn số 1895 YDCT-QLD.pdf
 
Danh sách các cơ sở đạt tiêu chuẩn GMP Dược liệu, Vị thuốc cổ truyền
Danh sách các cơ sở đạt tiêu chuẩn GMP Dược liệu, Vị thuốc cổ truyềnDanh sách các cơ sở đạt tiêu chuẩn GMP Dược liệu, Vị thuốc cổ truyền
Danh sách các cơ sở đạt tiêu chuẩn GMP Dược liệu, Vị thuốc cổ truyền
 

Último

METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 

Último (20)

METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 

Khiếu nại và thu hồi | Tài liệu GMP

  • 1. Module 5 | Slide 1 of 22 January 2006 Sections 5 and 6 Basic Principles of GMP Complaints and Recalls
  • 2. Module 5 | Slide 2 of 22 January 2006 Complaints and Recalls Objectives To identify the key issues in product complaint and recall handling To understand the specific requirements for organization, procedures and resources To understand and develop actions to resolve current issues applicable to you
  • 3. Module 5 | Slide 3 of 22 January 2006 5.1 Complaints and Recalls Complaints: Principle “All complaints and other information concerning potentially defective products must be carefully reviewed according to written procedures and corrective action should be taken.”
  • 4. Module 5 | Slide 4 of 22 January 2006 5.2 – 5.3 Complaints and Recalls Complaints Procedure - I Designated responsible person: To handle complaint Decide on measure to be taken May be authorized person - if not, must advise authorized person of results Sufficient support staff Access to records Written procedure (SOP): Describes action to be taken Includes need to consider a recall (e.g. possible product defect)
  • 5. Module 5 | Slide 5 of 22 January 2006 5.4 – 5.6 Complaints and Recalls Complaints Procedure - II  Thorough investigation: QC involved With special attention to establish whether "counterfeiting" may have been the cause Fully recorded investigation – reflect all the details  Due to product defect (discovered or suspected): Consider checking other batches Batches containing reprocessed product
  • 6. Module 5 | Slide 6 of 22 January 2006 5.7 – 5.9 Complaints and Recalls Complaints Procedure - III  Investigation and evaluation should result in appropriate follow-up actions May include a "recall"  All decisions and measures taken should be recorded  Referenced in batch records  Records reviewed - trends and recurring problems
  • 7. Module 5 | Slide 7 of 22 January 2006 5.10 Complaints and Recalls Other actions Inform competent authorities in case of serious quality problems such as: Faulty manufacture Product deterioration Counterfeiting
  • 8. Module 5 | Slide 8 of 22 January 2006 Complaints and Recalls Classification of Defects  If complaint is justified, then there has been a failure of the quality system  Once defect has been identified, company should be dealing with it in an appropriate way, even recall  The definition of defects is useful  The following system has been found in some countries (but it is not a WHO guideline): Critical defects Major defects Other defects
  • 9. Module 5 | Slide 9 of 22 January 2006 Complaints and Recalls Critical Defects Those defects which can be life-threatening and require the company to take immediate action by all reasonable means, whether in or out of business hours Examples Product labelled with incorrect name or incorrect strength Counterfeit or deliberately tampered-with product Microbiological contamination of a sterile product
  • 10. Module 5 | Slide 10 of 22 January 2006 Complaints and Recalls Major Defects  Those defects which may put the patient at some risk but are not life-threatening and will require the batch recall or product withdrawal within a few days Examples Any labelling/leaflet misinformation (or lack of information) which represents a significant hazard to the patient Microbial contamination of non-sterile products with some risk for patients Non-compliance to specifications (e.g. active ingredient assay)
  • 11. Module 5 | Slide 11 of 22 January 2006 Complaints and Recalls Other Defects Those defects which present only a minor risk to the patient — batch recall or product withdrawal would normally be initiated within a few days Examples Readily visible isolated packaging/closure faults Contamination which may cause spoilage or dirt and where there is minimal risk to the patient
  • 12. Module 5 | Slide 12 of 22 January 2006 Complaints and Recalls Reasons for Recall Customer complaint Detection of GMP failure after release Result from the ongoing stability testing Request by the national authorities Result of an inspection Known counterfeiting or tampering Adverse reaction reporting
  • 13. Module 5 | Slide 13 of 22 January 2006 Basic Principles of GMP Sample slide from slide no 13  The photo shows an active tablet in the row of placebos in a bi-phasic oral contraceptive blister pack Detection of GMP failure
  • 14. Module 5 | Slide 14 of 22 January 2006 6.1 Complaints and Recalls Product Recalls: Principle “There should be a system to recall from the market promptly and effectively, products known or suspected to be defective.”
  • 15. Module 5 | Slide 15 of 22 January 2006 Complaints and Recalls Definition Recall Removal from the market of specified batches of a product May refer to one batch or all batches of product
  • 16. Module 5 | Slide 16 of 22 January 2006 6.2 Complaints and Recalls Recall Procedure - I Designated responsible person (should be the "authorized person") To execute and coordinate recalls Decide on measure to be taken Sufficient support staff To handle all aspects and urgency of recall
  • 17. Module 5 | Slide 17 of 22 January 2006 6.3 – 6.4 Complaints and Recalls SOP for Recall Established, written and authorized Detailed actions to be taken Regularly reviewed and updated Capable of rapid operation to required level of distribution chain, e.g. hospital and pharmacy level Store recalled products in a secure, segregated area
  • 18. Module 5 | Slide 18 of 22 January 2006 6.6 Complaints and Recalls Distribution Records Distribution records available to authorized person and contain sufficient information on: Wholesalers Direct customers Export locations Batch numbers and quantities Including for clinical tests and medical samples to permit effective recall
  • 19. Module 5 | Slide 19 of 22 January 2006 6.5, 6.7, 6.8 Complaints and Recalls Progress of recall Monitor and record the progress during the recall Inform all competent authorities of all countries where the given product had been distributed Final report should include reconciliation between delivered and recovered products Record of the disposition of the product Effectiveness of procedure tested and evaluated from time to time!
  • 20. Module 5 | Slide 20 of 22 January 2006 Complaints and Recalls Group Session Collect 3 examples of complaints or recalls from your experience Describe the actions to be taken by the company or authority and the implications for all interested parties Suggest a classification of the complaint or recall into critical (life-threatening), major or other
  • 21. Module 5 | Slide 21 of 22 January 2006 Complaints and Recalls Possible Issues – I No response to justified complaints Response to unjustified complaints Failure to recall Failure to correct frequent complaints No resources to investigate No senior management support Senior management interference
  • 22. Module 5 | Slide 22 of 22 January 2006 Complaints and Recalls Possible Issues – II No distribution information/batch records No access to records Inability to contact government during holidays/weekends Disagreement on severity of defect

Notas del editor

  1. <number> जुलाइ 28, 2014 We are going to deal with an area of very great importance. The plan for this session is that we will present to you the critical aspects of complaint and recall handling for about 1 hour. You will then go into your groups to work there for about 1 hour. We will then reconvene for a plenary session and feedback, which will last about 1hours. There then a test paper followed by an answer session. This session will conclude the QA/QC aspects of the programme and we will have about half an hour for discussions on any of the issues raised.
  2. <number> जुलाइ 28, 2014 During this review we will look at the very specific requirements placed upon the organization, the procedures that are required and the resources that are needed, in particular, the people involved. We will also highlight the proper use of information regarding complaints as a tool for overall quality improvement. We then want you to look at some examples of current practice and to look at them with the advantage of hindsight. We expect that you will identify weaknesses in the way that these examples were handled and thus learn from these experiences.
  3. <number> जुलाइ 28, 2014 The product complaint principle is defined in the WHO GMP. The manufacturer must assume responsibility for the quality of the pharmaceutical products to ensure that they are fit for their intended use, comply with the requirements of the marketing authorization, and do not place the patient at risk because of inadequate safety, quality or efficacy. Complaints must be handled positively and carefully reviewed, and corrective actions must be taken as necessary. This can mean amending a manufacturing process as well as implementing a recall of a defective product from all markets where it has been distributed.
  4. <number> जुलाइ 28, 2014 First of all a written complaints handling procedure should be available. The basic requirements for such a procedure are: A designated person must be appointed with authority to conduct complaints reviews in accordance with the SOPs. The person designated may be the authorized person responsible for quality control. If not, then that QC person must be kept informed of all complaints being investigated. The designated person must have sufficient staff to be able to review all the complaints received in an effective and rapid manner. They must to be able to access all the relevant records concerning the product under discussion. Required actions are described. The complaint is acknowledged and a response to the customer is provided. Written and verbal comments are recorded.
  5. <number> जुलाइ 28, 2014 The QC department should be involved throughout the investigation. The investigation should be thorough and fully recorded– and reflect all the details of the investigation in the records. Special attention must be given to try and establish whether "counterfeiting" may have been the cause. If there is a product defect (discovered or suspected), then the company should consider checking other batches, and may have to check batches containing reprocessed product.
  6. <number> जुलाइ 28, 2014 Investigation and evaluation should result in appropriate follow up actions taken. This may include a "recall" of the product, or batch. All decisions and measures taken should be recorded. The complaint should also be referenced in batch records – and may thus help during the review or annual product review, trend analysis etc. Complaint records should be reviewed on a regular basis as defined in the SOP. Trends and recurring problems should be identified and proper action taken to prevent recurrence of the problem/cause. As complaints are investigated and records are built up, then trends may start to become clear. A regular review of complaint records to establish whether there is a trend for a particular product, dosage form, customer, distribution channel or similar should be undertaken. This is where the true value of a good complaints handling procedure shows. It may be that a particular formulation or particular machine is giving rise to complaints. This trend analysis process is an opportunity for continuous improvement. It may be that a particular customer is engaged in fraudulent behaviour.
  7. <number> जुलाइ 28, 2014 The competent authority must be informed of any serious quality problems that are revealed by the complaint investigation
  8. <number> जुलाइ 28, 2014 During complaints handling and especially in recall situations it is important to have clear guidance to define the magnitude of the problem. If an investigation into a complaint proves that the complaint is justified, then there has been a failure of the quality system resulting in a defective product becoming available. Once a very serious defect has been identified, it is important to be sure that the company is dealing with the recall in an appropriate way. How quickly should the company be responding to the problem? The definition of defects therefore is important. We are suggesting here a system of classification that may be helpful. Some countries have different approaches. This system has been in use in a number of countries and found to be useful. Classification of defects: Critical defects Major defects Other defects. This is a very difficult area requiring professional judgement in coming to the correct decision. The company should have procedures to call into operation to decide whether a recall is required and how quickly it should be implemented. These procedures should be discussed and agreed with the regulatory authority.
  9. <number> जुलाइ 28, 2014 Critical defects are those defects which can be life-threatening and which require the company to take immediate action by all reasonable means, as soon as the defect becomes apparent, whether in or out of business hours. This means that all wholesalers must be alerted and the necessary actions taken to commence recalling the product throughout the distribution chain. This illustrates how important distribution records are, including those of the wholesaler. Examples of critical defects are: Product labelled with incorrect name Counterfeit or deliberately tampered with product Microbiological contamination of a sterile product. It can be seen from the examples that it is critical to patient health that immediate action is taken. It may mean using radio and television news broadcasts to conduct the recall.
  10. <number> जुलाइ 28, 2014 Major defects are those defects which may put the patient at some risk but which are not life-threatening. They will require the recall of the batch or product withdrawal within a few days. In some countries this is specified as within 48 hours. Examples of major defects are: Any labelling/leaflet misinformation (or lack of information) which represents a significant hazard to the patient Microbial contamination of non-sterile products with some risks Non-compliance to specifications (e.g. active ingredient assay close to limits but out of specification). A country may decide on different time-scales for recalls, depending on the appropriate response for the product or defect concerned.
  11. <number> जुलाइ 28, 2014 Other defects are those defects which present only a minor risk to the patient. Any batch recall or product withdrawal would normally be initiated within a few days. In some countries this is specified as within five working days. Examples of such defect are: Readily visible isolated packaging/closure faults Contamination which may cause spoilage or dirt and where there is minimal risk to the patient. Again this shows a less speedy response to the situation which is in balance with the level of risk for the patient. Let us summarize at this point: It is important that complaints as well as potential recall situations result in the proper categorization of the problem. This means that the company will then undertake recalls or complaints handling with the correct level of urgency and not unduly alarm patients or the public. It is essential that the public retain a high level of confidence in the supply of pharmaceuticals. This confidence, however, must be justified.
  12. <number> जुलाइ 28, 2014 A recall situation can result from information entering a company in various ways: Customer complaints – these may be so serious as to initiate a recall. An example could be the evidence of a lack of sterility GMP deviations/results of a failure investigation The result from the QC stability programme Request by the regulatory authorities Result of an inspection Known counterfeiting or tampering Adverse drug reaction (ADR) reported, leading to a recall decision (however, an ADR does not automatically lead to a recall). The company must have a procedure in place that can be operated at all hours to decide how serious a defect is and whether it warrants a recall.
  13. <number> जुलाइ 28, 2014 Walls, floors, ceilings – smooth and easy to clean No ledges or areas where dust can accumulate Prevention of build-up of dirt and dust to avoid unnecessary risks of contamination
  14. <number> जुलाइ 28, 2014 The product recall principle is defined in the WHO GMP. The manufacturer must assume responsibility for the quality of the pharmaceutical products to ensure that they are fit for their intended use, comply with the requirements of the marketing authorization, and do not place the patient at risk because of inadequate safety, quality or efficacy. Recalls must be handled positively and carefully reviewed, and actions must be taken as necessary leading to an effective recall of defective product from all markets where it has been distributed.
  15. <number> जुलाइ 28, 2014 To deal with the topic of recalls we should first review some definitions: Recall is the removal from the market of specified batches or all batches of a product. Some countries refer to the recall of all batches as “withdrawal”.
  16. <number> जुलाइ 28, 2014 A designated person must be appointed with authority to conduct recalls in accordance with the procedures. The person designated may be the authorized person responsible for quality control. If not then that QC person must be kept informed of all recalls being conducted. The designated person must have sufficient staff to be able to undertake recalls in an effective and rapid manner with appropriate urgency. The designated person should normally be independent of sales and marketing departments and must have the status and authority to be able to carry out the procedure.
  17. <number> जुलाइ 28, 2014 The recall procedure must be written, authorized by at least the quality control manager, describe clearly the actions to be taken, and include a requirement that it is regularly checked and updated. It must be capable of rapid start-up, out of business hours if necessary. It should include a communications plan to enable all key personnel, and deputies in case of absence, to be contacted outside normal business hours. It is essential that all the authorities in all the countries to which the relevant batch or batches have been sent are informed of the recall. This contact may be done at government level (government-to-government) but not necessarily. It is the manufacturer’s responsibility to ensure that the competent authorities in each country are informed. The manufacturer should also inform importers of the product. The importers will probably be the holders of any product registration and will also know where the product has been distributed. Key contact telephone numbers for all authorities that may need to be contacted should be listed.
  18. <number> जुलाइ 28, 2014 Essential to the success of any recall is the quality of information contained in distribution records. The company is required to maintain in its records, accurate information on the quantity and batch number of any product it sends to wholesalers or its own direct customers. Full details must be kept of the names, addresses and telephone numbers of all customers. This point raises issues about the records that must be kept by distributors. We have plenty of examples where distributors fail to keep records that can be essential for a product recall. National authorities and manufacturers must continue to exercise pressure to ensure that distributors maintain records at batch number level.
  19. <number> जुलाइ 28, 2014 As the recall progresses in accordance with the written procedure, written progress reports must be kept showing that all stages of the recall procedure have been adhered to. A reconciliation must also be prepared, showing the total product quantity distributed and the total quantity returned, by batch. It should identify any areas where reconciliation has not been achieved and offer reasons why. A final report must be issued to cover all aspects of the recalls including lessons to be learnt for the future conduct of such recalls. The effectiveness of SOP must also be regularly checked and procedures modified accordingly in the light of any lessons learned. The effectiveness of the recall procedure can be tested by conducting a dummy recall of a particular product. This involves identifying a batch and then conducting a paper recall only to test out the systems. Such dummy recalls should be undertaken not only in normal office hours but also at the weekend and in the middle of the night. As goods are returned, they must be stored in secure storage away from all other goods until their fate is decided. Remaining stock of the suspect batch in the warehouse should also be moved into this secure storage. This is very important because there must be no risk of confusion with other batches that are good.
  20. <number> जुलाइ 28, 2014 This brings us to our question for the group session. You have one hour for discussion. The purpose behind this question is to get you to use real examples from your experience, examine what was done at the time and then think through what should have been done if all policies and procedures had been designed correctly and implemented properly. Your team here will move around the groups so please use them to help on any contentious issues. We will meet here again at _________ (insert appropriate time).
  21. <number> जुलाइ 28, 2014 Here are some possible issues that may arise in discussion (If discussion tends not to be lively you may care to use some of these as examples). The company may have difficulty in providing a reasoned response to a justified complaint. Senior management may prefer to ignore justified complaints. There may be an issue of loss of face. The company may have difficulty in confronting a customer with an unjustified complaint. How can the company tell a complaining customer that he/she is mistaken in the belief that the company has done wrong? The company may prefer not to recall a product for a variety of reasons. How do you handle the conflict that might arise in a company between the ethics of doing the right thing and the QA director retaining his/her job, for example? The company may not feel that it has the resources to correct a frequently occurring problem. Instead it prefers to pick up the complaints and handle them. How do you handle the situation where the owner of the company takes the decisions on how product complaints or recalls are to be handled and this does not conform to the GMP way?
  22. <number> जुलाइ 28, 2014 What are you going to do if there are no correct distribution or batch records of a product that may need to be recalled? How do you handle distributors who refuse to keep distribution records because “no one pays us to do that”? How do you handle the situation where the owner’s son is in charge of sales and distribution and refuses to let the QA manager see the distribution records when the QA manager is trying to investigate a product complaint. The company believes that a product needs to be recalled but it’s the start of the weekend. They need someone in the national authority to discuss the recall. They can’t get hold of anyone! What are you going to do? The company manages to speak to the government and they have a very different view of the urgency of the recall to the one that the company has. What are you going to do?